BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Furukori M, Imai K, Karasaki H, Watanabe K, Oikawa K, Miyokawa N, Taniguchi M, Furukawa H. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(47): 17949-17954 [PMID: 25548493 DOI: 10.3748/wjg.v20.i47.17949]
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17949.htm
Number Citing Articles
1
Hironari KATO, Kazuyuki MATSUMOTO. Current status of endoscopic ultrasound (EUS)-guided ablation therapy for pancreatic neuroendocrine neoplasms (PNENs)Suizo 2023; 38(4): 229 doi: 10.2958/suizo.38.229
2
T. J. Musholt, F. M. Watzka. Neuroendokrine Neoplasien des gastroenteropankreatischen SystemsDer Gastroenterologe 2015; 10(5): 410 doi: 10.1007/s11377-015-0003-2
3
Liang-Yu Lin, Yi-Chen Yeh, Chia-Huei Chu, Justin G.S. Won, Yi-Ming Shyr, Yee Chao, Chung-Pin Li, Shin-E Wang, Ming-Huang Chen. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumorsMedicine 2017; 96(41): e8262 doi: 10.1097/MD.0000000000008262
4
Young Jin Yoo, Seok Jeong Yang, Ho Kyoung Hwang, Chang Moo Kang, Hogeun Kim, Woo Jung Lee. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the PancreasMedicine 2015; 94(36): e1404 doi: 10.1097/MD.0000000000001404
5
David S. Klimstra, Himisha Beltran, Rogerio Lilenbaum, Emily Bergsland. The Spectrum of Neuroendocrine Tumors: Histologic Classification, Unique Features and Areas of OverlapAmerican Society of Clinical Oncology Educational Book 2015; (35): 92 doi: 10.14694/EdBook_AM.2015.35.92
6
Shreya Mehta, Philip R. de Reuver, Preetjote Gill, Juliana Andrici, Lisa D’Urso, Anubhav Mittal, Nick Pavlakis, Stephen Clarke, Jaswinder S. Samra, Anthony J. Gill. Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine TumorsMedicine 2015; 94(40): e1281 doi: 10.1097/MD.0000000000001281